Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Oliver Luxxe Assets LLC

Oliver Luxxe Assets LLC raised its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% during the fourth quarter, HoldingsChannel reports. The fund owned 17,056 shares of the company’s stock after acquiring an additional 544 shares during the quarter. Oliver Luxxe Assets LLC’s holdings in Addus HomeCare were worth $2,138,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Quarry LP bought a new position in shares of Addus HomeCare during the third quarter worth about $28,000. Quest Partners LLC bought a new stake in Addus HomeCare in the second quarter valued at about $31,000. Farther Finance Advisors LLC raised its stake in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares in the last quarter. Sandia Investment Management LP bought a new position in Addus HomeCare during the 2nd quarter worth approximately $58,000. Finally, GAMMA Investing LLC grew its position in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after acquiring an additional 191 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on ADUS shares. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Stephens raised their target price on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, KeyCorp began coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Addus HomeCare has an average rating of “Buy” and a consensus target price of $133.67.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,750 shares of company stock valued at $4,930,750. Company insiders own 4.60% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS traded up $0.53 during midday trading on Monday, hitting $125.12. 107,222 shares of the company’s stock were exchanged, compared to its average volume of 124,511. Addus HomeCare Co. has a twelve month low of $85.94 and a twelve month high of $136.12. The firm has a market cap of $2.27 billion, a P/E ratio of 28.63, a PEG ratio of 2.11 and a beta of 1.00. The stock’s 50 day moving average price is $125.12 and its 200-day moving average price is $125.83.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 EPS. On average, analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.